Reviewing Acutus Medical (NASDAQ:AFIB) and KORU Medical Systems (NASDAQ:KRMD)

KORU Medical Systems (NASDAQ:KRMD) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for KORU Medical Systems and Acutus Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1	0	4	0	2.60
Acutus Medical	0	0	0	0	0.00

KORU Medical Systems currently has a consensus target price of $7.00, indicating a potential upside of 97.18%. Given KORU Medical Systems’ stronger consensus rating and higher probable upside, analysts plainly believe KORU Medical Systems is more favorable than Acutus Medical.

Institutional & Insider Ownership

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by insiders. Comparatively, 5.2% of Acutus Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares KORU Medical Systems and Acutus Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-4.03%	-10.63%	-6.51%
Acutus Medical	-272.74%	-311.64%	-11.57%

Volatility & Risk

KORU Medical Systems has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500. Comparatively, Acutus Medical has a beta of 5.7, suggesting that its share price is 470% more volatile than the S&P 500.

Valuation & Earnings

This table compares KORU Medical Systems and Acutus Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$45.11 million	3.61	-$2.64 million	($0.04)	-88.75
Acutus Medical	$7.16 million	0.00	-$81.66 million	($0.11)	-0.00

KORU Medical Systems has higher revenue and earnings than Acutus Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Acutus Medical, indicating that it is currently the more affordable of the two stocks.

Summary

KORU Medical Systems beats Acutus Medical on 12 of the 14 factors compared between the two stocks.

About KORU Medical Systems

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

About Acutus Medical

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.